Ecosystem

Curetopia, the first BioDAO on Solana, is launching today on the Bio Launchpad.‍ The DAO will target the $1T+ rare disease market and is being led by Dr. Ethan O. Perlstein, a Y Combinator alum, Harvard PhD and biotech founder who recently brought a rare disease drug to Phase 3 trials.

January was a historic month for the Bio ecosystem: the BIO token went live on Ethereum and Solana, laying the groundwork for the launch of Bio's new launchpad and liquidity protocol.

It's been a little over a week since BIO went live Jan. 3 on Ethereum & Binance. Then last Thursday Jan. 9, BIO officially bridged to Solana. The focus now turns to deploying Bio's liquidity protocol & launchpad cross-chain (Base included), BIO staking & curation, and launching new BioDAOs.

A primer on Long COVID Labs, one of the latest additions into the BIO Incubator. Long COVID Labs (LCL) aims to accelerate breakthrough treatments to cure the 100M+ Long COVID patients still struggling to find solutions from Big Pharma.

After the success of the first generation of BioDAOs incubated by BIO and our ongoing Genesis launch still underway, we are proud to unveil the first BioDAOs admitted into Cohort 2.

A DAO-based Nootropics community could facilitate more efficient onboarding and experimentation to help members arrive at their optimal stack.

BIO Genesis is live and Liquid Science is flowing. Here's what's happening across DeSci's fastest-growing network.

BioDAOs are poised to transform scientific research and commercialization. After successfully incubating cohort one, we’re inviting biotech builders to apply for our upcoming second cohort.

Key growth takeaways from BIO’s first DeSci Data Room — and what it could mean for you.